Pharma Company Advances Fair Trials Representation With Structured Patient Engagement Strategy

Client Challenge

Our client is a global pharmaceutical company specializing in respiratory, neonatology, rare diseases, and specialty care. While they did conduct some standalone activities aimed at ensuring comprehensive, fair and balanced representation in their clinical trials, they did not have a systematic approach to enhance the recruitment and retention of diverse patient populations. At the same time, they wanted to ensure regulatory compliance and alignment with industry best practices. They sought to improve accessibility and inclusivity in clinical trials, increase regulatory alignment with evolving requirements, and strengthen their industry leadership in equitable clinical research practices. 

The client looked for a provider that could build a comprehensive, structured framework tailored to their clinical trial processes. The provider also needed to deliver a practical roadmap with clear action items for implementation. 

The client company selected Alira Health due to the company’s deep expertise in integration within clinical research and structured, multi-phase approach ensuring regulatory alignment. 

Our Approach

Alira Health’s Patient Engagement team proposed a tailored framework to ensure comprehensive and fair representation of participants and roadmap to enhance balanced patient recruitment and retention in clinical trials. The gap analysis of client’s existing activities identified the real, data-driven gaps before the team designed the new strategic, systematic framework. Alira Health’s evidence-based, structured methodology enabled the client to integrate the framework into their trial processes.  

Based on the planned strategy, Alira Health structured the project into five key modules: 

Module 1: secondary research and benchmarking 

• Performed an in-depth review of guidelines, literature, and competitor practices across multiple geographies 

• Summarized findings into a clear, actionable delivery deck for internal alignment 

Module 2: internal process evaluation and stakeholder Interviews 

• Conducted 12 stakeholder interviews to assess current clinical operation process and activities. 

• Identified gaps and challenges in client’s existing clinical workflows 

Module 3: gap analysis 

• Consolidated findings from Modules 1 and 2 into a gap analysis report 

• Identified key areas where activities towards comprehensive, fair and balanced representation needed further integration into clinical trials 

Module 4: development of a tailored framework and roadmap 

• Created a detailed roadmap with actionable steps for implementation 

• Developed a RACI-like matrix to define stakeholder responsibilities 

• Delivered a comprehensive close-out report 

Module 5: Advisory board with external experts on accessibility and inclusivity 

• Conducted an external expert panel discussion to validate and refine the client’s strategy 

• Finalized a structured framework based on insights gathered

Outcomes

From this project, the pharma company received a comprehensive, structured framework for clinical trials, along with a detailed roadmap outlining key implementation steps and a refined strategy validated by experts. The client now has a clear, evidence-based strategy for integrating activities towards comprehensive, fair and balanced representation in clinical trials and an improved understanding of regulatory compliance on the matter. And they have key process improvements for patient recruitment and retention. 

Additionally, the client benefited from enhanced awareness among internal teams on best practices to enhance accessibility, inclusivity comprehensive, fair and balanced representation and a strengthened business case for leadership on investing in activities on the matter. They also increased confidence in their regulatory alignment and industry leadership. 

Key Success Factors

The project was successful due to Alira Health’s deep understanding of patient needs, strengthened by a strong consulting background. The company provided strategic advice and tactics backed by a rigorous data-driven methodology, ensuring well-informed decision-making. Its proven track record in designing and implementing patient engagement strategies across clinical stages of product development further contributed to the project’s success.